2017
DOI: 10.1002/anie.201709082
|View full text |Cite
|
Sign up to set email alerts
|

Organoiridium Photosensitizers Induce Specific Oxidative Attack on Proteins within Cancer Cells

Abstract: Strongly luminescent iridium(III) complexes, [Ir(C,N)2(S,S)]+ (1) and [Ir(C,N)2(O,O)] (2), containing C,N (phenylquinoline), O,O (diketonate), or S,S (dithione) chelating ligands, have been characterized by X‐ray crystallography and DFT calculations. Their long phosphorescence lifetimes in living cancer cells give rise to high quantum yields for the generation of 1O2, with large 2‐photon absorption cross‐sections. 2 is nontoxic to cells, but potently cytotoxic to cancer cells upon brief irradiation with low do… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
65
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 116 publications
(66 citation statements)
references
References 47 publications
1
65
0
Order By: Relevance
“…In PDT, major efforts have been devoted, over the years, to the development of new photosensitizers, with the purpose of increasing light penetration in tissues and to enhance the spatial precision of treatments . An example towards such photosensitizers is the novel organoiridium complex reported by Sadler and co‐workers . The photosensitizer exhibited a long phosphorescence lifetime and allowed the selective induction of cancer cell death in cell cultures by causing oxidative damage on key His residues, which were overexpressed in tumor cells.…”
Section: Photocatalytic Modification Of a Residue At The Single Aminomentioning
confidence: 99%
See 1 more Smart Citation
“…In PDT, major efforts have been devoted, over the years, to the development of new photosensitizers, with the purpose of increasing light penetration in tissues and to enhance the spatial precision of treatments . An example towards such photosensitizers is the novel organoiridium complex reported by Sadler and co‐workers . The photosensitizer exhibited a long phosphorescence lifetime and allowed the selective induction of cancer cell death in cell cultures by causing oxidative damage on key His residues, which were overexpressed in tumor cells.…”
Section: Photocatalytic Modification Of a Residue At The Single Aminomentioning
confidence: 99%
“…[10a, 60] An example towards such photosensitizers is the novel organoiridium complexr eported by Sadler and co-workers. [61] The photosensitizer exhibited a long phosphorescencel ifetime and allowed the selectivei nductiono fc ancer cell death in cell cultures by causingo xidative damage on key His residues,w hich were overexpressed in tumor cells.…”
Section: Histidinementioning
confidence: 99%
“…However, small molecules including thioflavin T derivatives, riboflavin, or porphyrin, are easily aggregated to decrease photooxidative efficiency . In addition, the short lifetime of singlet oxygen ( 1 O 2 ) (<200 ns) as well as the short diffusion distance of 1 O 2 (≈1 μm) also abate their efficiency. Moreover, reactive oxygen species (ROS) can simultaneously destroy normal cells and tissues .…”
Section: Methodsmentioning
confidence: 99%
“…However, FDA approved Pt drugs includes only three name (cisplatin, oxaliplatin and carboplatin for cancer chemotherapy, due to inappropriate distribution in cell and inactivation by some cellular mechanism . These open up a great scope for researchers of medicinal inorganic chemistry to design and synthesize metallonuclease agents, which can specifically interact with the tumor cell and damage cellular DNA damage by forming metal‐DNA adduct, and a wide range of transition‐metal based biologically active compounds are currently under consideration for future development …”
Section: Introductionmentioning
confidence: 99%